Supernus Pharmaceuticals (SUPN) Misses Q2 Earnings Estimates

Supernus Pharmaceuticals (SUPN) came out with quarterly earnings of $0.36 per share, missing the Zacks Consensus Estimate of$ 0.37 per share. This compares to loss of $0.02 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of -2.70%. A quarter ago, it was expected that this drugmaker would post earnings of$ 0.39 per share when it actually produced break-even earnings, delivering a surprise of -100%. Over the last four quarters, th ...